MedPath

Resiliency Programming for Caregivers of Children with Learning and Attentional Difficulties

Not Applicable
Active, not recruiting
Conditions
Stress
Parenting
Learning Disabilities, Child
Attention Difficulties
Interventions
Behavioral: SMART-3RP
Behavioral: Health Education Program
Registration Number
NCT06492278
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This is a randomized open pilot trial enrolling up to 40 co-primary caregivers of children with LAD. Participants will be randomized to receive either mind-body resiliency group (SMART-LAD, intervention) or an evidence-based group intervention Health Education Program (HEP, control) which is a multiple behavior change program that addresses sleep, exercise, nutrition, substance use, and working with one's healthcare team. Both the SMART-3RP and HEP programs have been modified based on adaptions from our previous qualitative study.

Detailed Description

The primary objective of this protocol is to conduct an open pilot to elicit initial quantitative and qualitative feedback regarding feasibility and acceptability of the interventions (SMART-3RP and HEP) that we have refined. Both groups are designed to improve well-being for caregivers experiencing stress-related to caring for a child with LAD.

The investigators will ask participants to complete approximately 15-minute survey batteries via REDCap at baseline and after the 8-week program, including assessments of intervention feasibility and acceptability as well as psychosocial outcomes. To inform plans for ongoing program refinement, the investigators will also elicit specific feedback regarding study assessment tools, recruitment procedures, and group composition.

Results will be used to inform a larger randomized trial.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • English-speaking
  • Age 18 or older
  • Ability to participate in group, virtual sessions including access to computer, tablet, or smartphone, and internet
  • Parents or guardians of a child (< age 18) with LAD.
Exclusion Criteria
  • Parents with significant psychiatric conditions (i.e., active suicidality or psychosis) or who are otherwise unable to participate, at the investigators' clinical discretion.
  • Only one parent per family can participate.
  • Unwilling or unable to participate in the study
  • Considered medically or otherwise unable to participate by the study PI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SMART-3RPSMART-3RPThis is an adapted 8-session group program of the Relaxation Response Resiliency Program (3RP) for parents of children with LAD.
Health Education ProgramHealth Education ProgramThis is an adapted 8-session group program to provide health behavior education.
Primary Outcome Measures
NameTimeMethod
Feasibility of the refined interventions (SMART-3RP and HEP)Approximately 3 months (approximately 8-10 weeks after intervention start)

Rates of intervention attendance (# of sessions), rates of participant recruitment (%) enrollment.

Acceptability of the refined interventions (SMART-3RP and HEP)Approximately 3 months (approximately 8-10 weeks after intervention start)

Likert ratings of group comfort and cohesiveness.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MGH

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath